Clinical trials update from the annual scientific session of the American College of Cardiology 2006.
Cannon
Christopher P
CP
Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. cpcannon@partners.org
Bhatt
Deepak L
DL
D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D006328:Cardiac Catheterization; D002309:Cardiology / Q000639:trends; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000150:complications; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012955:Societies, Medical; D015607:Stents; D015912:Thrombolytic Therapy; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States
D017984:Enoxaparin; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin